Showing results (301-310 of 411) with videos related to

Sort By:
Pageof 42
Neurology. Clinical Practice|December 25, 2025
Advancing Early Detection of Alzheimer Disease in the Primary Care Setting in the United StatesMichelle M Mielke, H Ricky Kurzman, Yan Helen Hu, et al.
JAMA Psychiatry|August 28, 2014
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer diseaseRonald Lautner, Sebastian Palmqvist, Niklas Mattsson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 29, 2016
Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to orangesSid E O'Bryant, Simone Lista, Robert A Rissman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 27, 2025
Risk prediction of mild cognitive impairment using electronic health record dataGang Li, Bryan Cobb, Todd M Nelson, et al.
Neurology|July 3, 2016
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersClifford R Jack, David A Bennett, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2013
The future of blood-based biomarkers for Alzheimer's diseaseKim Henriksen, Sid E O'Bryant, Harald Hampel, et al.
Neurobiology of Aging|June 21, 2011
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's diseaseMichael Ewers, Susanne Schmitz, Oskar Hansson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2015
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter studyMichael Ewers, Niklas Mattsson, Lennart Minthon, et al.
Neuropharmacology|May 15, 2020
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discoveryHarald Hampel, Andrea Vergallo, Filippo Caraci, et al.
The Lancet. Neurology|March 4, 2018
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational studyBruno Dubois, Stephane Epelbaum, Francis Nyasse, et al.
Pageof 42